EuropeSouth AsiaAsia PacificAmericasMiddle EastAfricaBBC HomepageWorld ServiceEducation
News image
News image
News image
News imageNews image
News image
Front Page
News image
World
News image
UK
News image
UK Politics
News image
Business
News image
Sci/Tech
News image
Health
News image
Education
News image
Sport
News image
Entertainment
News image
Talking Point
News image
News image
News image
On Air
Feedback
Low Graphics
Help
News imageNews imageNews image
News imageWednesday, June 17, 1998 Published at 18:55 GMT 19:55 UK
News image
News image
Health
News image
Drug offers hope for Alzheimer's Disease
News image
Drug stimulates growth of brain cells
News image
A drug that helps to heal broken bones has turned out to repair brains as well.

The growth protein may speed the recovery of stroke victims, and might even restore some of the memory loss of Alzheimer's disease, according to New Scientist magazine.

A study of osteogenic protein-1 (OP-1), a man-made bone growth agent that repairs several types of damaged tissues, showed it helped rats to regain lost movement in their limbs after a stroke.

Damaged brain cells

"It works by rewiring the connections around the damaged brain cells," the magazine said. "There is also a chance that the protein may be able to improve memory in Alzheimer's patients."

Creative BioMolecules of Massachusetts developed the protein to bridge the gaps between broken bones but the company also discovered that it could stimulate the growth of dendrites, projections on brain nerve cells that receive signals to control the movement of impulses.

Test their reactions


[ image: Drug was tested on rats]
Drug was tested on rats
Marc Charette of Creative BioMolecules and colleagues at Harvard Medical School and Massachusetts General Hospital induced strokes in rats and injected the protein into their brains to test their reactions.

The researchers measured how easily the rats could place their limbs on a nearby platform. The rodents given OP-1 recovered faster than the animals that didn't receive the protein. Higher doses of the protein also induced a quicker recovery.

"The region of the brain that is damaged dies, but the protein rewires the circuitry around the damage, through tissue surviving the stroke," Charette told the magazine.

He added that OP-1 is the first protein that seems to repair dendrites, which are destroyed by Alzheimer's disease.

Creative BioMolecules, which collaborated with the medical technology company Stryker Corp on OP-1, is testing mice to see whether the protein can improve memory. Charette said if animals tests are completed successfully clinical trials of the protein could be possible in a year's time.

News image


Advanced options | Search tips


News image
News image
News imageBack to top | BBC News Home | BBC Homepage |
News image

News imageNews imageNews image
Health Contents
News image
News imageBackground Briefings
News imageMedical notes
News imageRelevant Stories
News image
05 Jun 98�|�Health
Scientists find dementia gene
News image
01 Jun 98�|�Latest News
Brain links taste and disgust
News image
27 May 98�|�Medical notes
Stroke
News image

News image
News image
News image
News imageInternet Links
News image
New Scientist
News image
Alzheimer's Disease Society
News image
News imageNews image
The BBC is not responsible for the content of external internet sites.

News image
News image
News image
News imageIn this section
News image
Disability in depth
News image
Spotlight: Bristol inquiry
News image
Antibiotics: A fading wonder
News image
Mental health: An overview
News image
Alternative medicine: A growth industry
News image
The meningitis files
News image
Long-term care: A special report
News image
Aids up close
News image
From cradle to grave
News image
NHS reforms: A guide
News image
NHS Performance 1999
News image
From Special Report
NHS in crisis: Special report
News image
British Medical Association conference '99
News image
Royal College of Nursing conference '99
News image

News image
News image
News image